← Leaderboards
Martin E Hemler
Dana-Farber Cancer Institute
$14,012,219
Attributed
$14,012,219
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $894K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$14,012,219 · 6
By mechanism
R01$14,005,219 · 5
R13$7,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Integrins”
- Timothy A Springer · Boston Children'S Hospital$50,095,849
- David A Cheresh · Scripps Research Institute$28,587,859
- Mark Howard Ginsberg · University Of California, San Diego$28,221,483
- Martin A. Schwartz · Yale University$23,274,443
- M. Amin Arnaout · Massachusetts General Hospital$23,064,887
- Edward Franklin Plow · Cleveland Clinic Foundation$22,902,830
Research focus
IntegrinsProteinsIn VivoIn VitroPhosphorylationPlayMutateCellsSiteComplexMalignant NeoplasmsInsightCell MotilityNeoplastic CellAdhesionsGrowthTumorCell AdhesionSignal TransductionPalmitoylationLaboratory MouseNeoplasm MetastasisTumor ProgressionMalignant Breast Neoplasm
Grant awards (47)
Targeting of tumor cell DHHC3 to enhance anti-cancer immunity$380,201
R01 · FY2024 · CA · contact PI
Targeting of tumor cell DHHC3 to enhance anti-cancer immunity$392,207
R01 · FY2023 · CA · contact PI
Targeting of tumor cell DHHC3 to enhance anti-cancer immunity$392,207
R01 · FY2022 · CA · contact PI
Targeting of tumor cell DHHC3 to enhance anti-cancer immunity$400,211
R01 · FY2021 · CA · contact PI
Targeting of tumor cell DHHC3 to enhance anti-cancer immunity$400,211
R01 · FY2020 · CA · contact PI
Support of carcinoma metastasis by integrin a6-CD151-PKC complexes$318,839
R01 · FY2019 · CA · contact PI
Support of carcinoma metastasis by integrin a6-CD151-PKC complexes$328,700
R01 · FY2018 · CA · contact PI
Support of carcinoma metastasis by integrin a6-CD151-PKC complexes$328,700
R01 · FY2017 · CA · contact PI
Support of carcinoma metastasis by integrin a6-CD151-PKC complexes$328,700
R01 · FY2016 · CA · contact PI
Support of carcinoma metastasis by integrin a6-CD151-PKC complexes$328,700
R01 · FY2015 · CA · contact PI
Alpha6 integrin complexes and tumor progression$278,166
R01 · FY2013 · CA · contact PI
Alpha6 integrin complexes and tumor progression$295,993
R01 · FY2012 · CA · contact PI
Characterization of tetraspanin-EWI protein complexes and functions$317,033
R01 · FY2011 · GM · contact PI
Alpha6 integrin complexes and tumor progression$296,064
R01 · FY2011 · CA · contact PI
Characterization of tetraspanin-EWI protein complexes and functions$320,740
R01 · FY2010 · GM · contact PI
Alpha6 integrin complexes and tumor progression$304,140
R01 · FY2010 · CA · contact PI
Characterization of tetraspanin-EWI protein complexes and functions$324,490
R01 · FY2009 · GM · contact PI
Alpha6 integrin complexes and tumor progression$300,752
R01 · FY2009 · CA · contact PI
Characterization of tetraspanin-EWI protein complexes and functions$325,000
R01 · FY2008 · GM · contact PI
Investigation of integrin alpha6beta4 microdomain functions$285,031
R01 · FY2008 · CA · contact PI
Interactions of CD147 Involved in MMP Induction$283,923
R01 · FY2008 · CA · contact PI
Linker functions for tetraspanins CD9 and CD81$291,851
R01 · FY2007 · GM · contact PI
Investigation of integrin alpha6beta4 microdomain functions$285,230
R01 · FY2007 · CA · contact PI
Interactions of CD147 Involved in MMP Induction$283,923
R01 · FY2007 · CA · contact PI
Linker functions for tetraspanins CD9 and CD81$300,567
R01 · FY2006 · GM · contact PI
Interactions of CD147 Involved in MMP Induction$292,403
R01 · FY2006 · CA · contact PI
Investigation of integrin alpha6beta4 microdomain functions$270,618
R01 · FY2006 · CA · contact PI
Linker functions for tetraspanins CD9 and CD81$307,800
R01 · FY2005 · GM
Interactions of CD147 Involved in MMP Induction$278,940
R01 · FY2005 · CA
Investigation of integrin alpha6beta4 microdomain functions$277,340
R01 · FY2005 · CA
NOVEL INTEGRIN-CD151-PKC SIGNALING COMPLEX$331,740
R01 · FY2004 · CA
Linker functions for tetraspanins CD9 and CD81$307,800
R01 · FY2004 · GM
Investigation of integrin alpha6beta4 microdomain functions$277,543
R01 · FY2004 · CA
Interactions of CD147 Involved in MMP Induction$276,074
R01 · FY2004 · CA
NOVEL INTEGRIN-CD151-PKC SIGNALING COMPLEX$331,740
R01 · FY2003 · CA
TRANSMEMBRANE LINKER FUNCTIONS OF TM4SF PROTEINS$299,250
R01 · FY2003 · GM
INSIDE/OUT REGULATION OF BETA 1 INTEGRIN FUNCTION$220,883
R01 · FY2003 · CA
NOVEL INTEGRIN-CD151-PKC SIGNALING COMPLEX$332,225
R01 · FY2002 · CA
TRANSMEMBRANE LINKER FUNCTIONS OF TM4SF PROTEINS$299,395
R01 · FY2002 · GM
INSIDE/OUT REGULATION OF BETA 1 INTEGRIN FUNCTION$214,504
R01 · FY2002 · CA
FASEB Summer Conference--Advance in Tetraspanin Research$7,000
R13 · FY2002 · CA
TRANSMEMBRANE LINKER FUNCTIONS OF TM4SF PROTEINS$300,271
R01 · FY2001 · GM
NOVEL INTEGRIN-CD151-PKC SIGNALING COMPLEX$291,546
R01 · FY2001 · CA
INSIDE/OUT REGULATION OF BETA 1 INTEGRIN FUNCTION$208,306
R01 · FY2001 · CA
TRANSMEMBRANE LINKER FUNCTIONS OF TM4SF PROTEINS$301,000
R01 · FY2000 · GM
NOVEL INTEGRIN-CD151-PKC SIGNALING COMPLEX$291,970
R01 · FY2000 · CA
INSIDE/OUT REGULATION OF BETA 1 INTEGRIN FUNCTION$202,292
R01 · FY2000 · CA